Advertisement
Advertisement
TLSI
TriSalus Life Sciences, Inc. Common Stock
2.17
USDSponsored
-0.28
-11.22%
Nov 19, 15:59 UTC -5
Closed
After-Market
2.46
+0.28
+12.87%
TriSalus Life Sciences, Inc. Common Stock (TLSI) Earnings
TLSI Earnings Reports
Positive Surprise Ratio
TLSI beat 4 of 12 last estimates.
33%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
TriSalus Life Sciences, Inc. Common Stock earnings per share and revenue
On Nov 10, 2026, TLSI reported earnings of -0.15 USD per share (EPS) for Q3 26, missing the estimate of -0.13 USD, resulting in a -14.85% surprise. Revenue reached 12.88 million, compared to an expected 14.30 million, with a -9.97% difference. The market reacted with a -11.49% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were TriSalus Life Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, TriSalus Life Sciences, Inc. Common Stock reported EPS of -$0.15, missing estimates by -14.85%, and revenue of $12.88M, -9.97% below expectations.
How did the market react to TriSalus Life Sciences, Inc. Common Stock's Q3 2026 earnings?
The stock price moved down -11.49%, changed from $3.22 before the earnings release to $2.85 the day after.
When is TriSalus Life Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for TriSalus Life Sciences, Inc. Common Stock's next earnings report?
Based on --
analysts, TriSalus Life Sciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.